ロード中...
Development of a clinical decision tool to reduce diagnostic testing for primary aldosteronism in patients with difficult-to-control hypertension
BACKGROUND: Satisfactory tools to preclude low-risk patients from intensive diagnostic testing for primary aldosteronism (PA) are lacking. Therefore, we aimed to develop a decision tool to determine which patients with difficult-to-control hypertension have a low probability of PA, thereby limiting...
保存先:
| 出版年: | BMC Endocr Disord |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7191700/ https://ncbi.nlm.nih.gov/pubmed/32349748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12902-020-0528-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|